Organisation paid for research Program year 2025 Source: CMS Open Payments

Barnet Dulaney Perkins Eye Ctr

Neither a doctor nor a teaching hospital

Research payments

$2,046,276

182 payments

Through program year 2025, Barnet Dulaney Perkins Eye Ctr is reported as receiving $2,046,276 in research payments, across 182 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$430,120	32
2024	Research	$523,414	73
2023	Research	$419,142	39
2022	Research	$673,601	38

Breakdown

Who paid Research payments · program years 2022–2025

Genentech, Inc. $2,046,276 182 payments

Studies the money was for Research payments · program years 2022–2025

Port Delivery System of Ranibizumab Extension Study $567,442 49 payments
Mad to Assess the Safety Tolerability and PK PD in Namd Patients $442,279 37 payments
Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $312,291 20 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $195,472 11 payments
A Phase III Study to Investigate Ro7200220 in Patients With Uveitic MacUlar Edema $155,489 22 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $136,608 17 payments
Faricimab Dme Long Term Extension Rhone X $88,368 14 payments
Vabysmo PFS $56,831 3 payments
Ah and Imaging Biomarker Study $42,865 3 payments
A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $29,991 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.